Protein Painting reveals hidden protein-protein interaction domains
蛋白质绘画揭示了隐藏的蛋白质-蛋白质相互作用域
基本信息
- 批准号:8547427
- 负责人:
- 金额:$ 24.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-01 至 2015-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffinityAffinity ChromatographyAlkanesulfonatesAlkylationAmino AcidsAnthracenesAntibodiesAntibody SpecificityAreaAutomobile DrivingBindingBinding SitesBiological AssayBiopsy SpecimenCancer BiologyCancer ModelCell Culture TechniquesCellsChemicalsChemistryComplexCytoplasmic ProteinDataDevelopmentDigestionDissociationDrug TargetingDyesEventFutureGene Expression RegulationGeneticIndividualInterleukin-1InterleukinsLigandsMalignant NeoplasmsMasksMass Spectrum AnalysisMediatingMembrane ProteinsMethodsMolecularNuclear ProteinsPaintPeptide HydrolasesPhosphorylationPopulationProtein BindingProtein Binding DomainProtein MicrochipsProtein RegionProteinsProteomicsResolutionSideSignal TransductionSiteSolutionsTechnologyTherapeuticTimeTissue SampleTranscription Factor 3TrypsinWestern BlottingX-Ray CrystallographyX-Ray Tomographyarginyllysinebasecancer cellchymotrypsincrosslinkinnovationmembernew technologynext generationnovelprotein foldingprotein misfoldingprotein protein interactionpublic health relevancereceptorscreeningsmall moleculetumoryeast two hybrid system
项目摘要
DESCRIPTION (provided by applicant): We propose the creation of a wholly novel technology "protein painting", for the rapid, direct isolation and sequencing of hidden native protein-protein
interaction domains. Protein-protein interactions are the basis of virtually all functional moleculr events driving cancer cell signaling and gene regulation. Currently no technology exists to directly isolate and sequence unknown interaction domains, or to directly detect whether known protein-protein binding domains are in contact in a cellular or tissue sample of native proteins. Tracking the interface domains between interacting proteins, or within misfolded proteins, is the basis for the next generation of therapies that block the molecular interactions driving cancer. We will create protein paint chemistries, a novel panel of synthetic organic small molecules that bind to protein molecules with high affinity and mask all the protease cleavage sites of the protein. We will use our new protein painting chemistry to isolate and sequence protein-protein interaction domains of cancer related proteins. Interacting native proteins in solution are painted
with a palette of paint molecules that coat the exposed surfaces of the proteins but do not have access to the internal protein-protein contact domains. Thus if two native proteins are bound together, the interface domains will remain non-painted. The protein paints coat with a high resolution (<3 amino acids). Following painting, the interacting proteins are dissociated, to reveal and expose the non-painted interaction domains that were inaccessible to the paint molecules when the proteins were interacting in their native state. Painted regions are masked from proteinase cleavage or antibody recognition, even after dissociation. The dissociated painted proteins can then be subjected to proteinase cleavage (e.g. trypsin) and ms sequencing, or antibody probing. Since the paint blocks the proteinase cleavage sites that are not in contact, proteinase fragments for ms sequencing will only be generated from the non-painted areas exclusively comprising the interaction domains. The Aims follow our discovery of the masking of trypsin cleavage sites (carboxyl side of arginine & lysine) by sulfonated anthracene organic dye molecule "paints" such as disodium 1-amino-9,10- dioxo-4- [3- (2- sulfonatooxyethylsulfonyl) anilino] anthracene -2 -sulfonate, which achieve a high degree of trypsin cleavage site coverage. We verified protein painting capabilities by direct ms sequencing of the hidden interaction domain of interleukin-1¿ bound to its receptor. In the past this domain could only be predicted by X- Ray crystallography. Our transformative technology addresses a broad and critical unmet need in cancer biology and cancer therapeutics. We envision that the technology can be used in the future to decipher interaction domains from tumor biopsy samples or cell cultures treated with a ligand or a therapy. Antibody binding assays can be used to quantify the number/type of occupied binding sites in a cell lysate. We will create a panel of 12 protein paints, and apply the paints to 3 model cancer related protein-protein interactions:1) receptor-ligand, 2) phosphorylation mediated association, and 3) transcription factor complexes.
描述(申请人提供):我们提议创建一种全新的技术“蛋白质绘画”,用于快速、直接分离和测序隐藏的天然蛋白质-蛋白质
相互作用域。蛋白质-蛋白质相互作用是几乎所有驱动癌细胞信号传导和基因调控的功能分子事件的基础。目前还不存在直接分离和测序未知相互作用结构域或直接检测已知蛋白质-蛋白质结合结构域是否在天然蛋白质的细胞或组织样品中接触的技术。跟踪相互作用蛋白质之间或错误折叠蛋白质内的界面结构域是下一代阻断驱动癌症的分子相互作用的疗法的基础。我们将创建蛋白质涂料化学,一种新型的合成有机小分子面板,以高亲和力结合蛋白质分子,并掩盖蛋白质的所有蛋白酶切割位点。我们将使用我们新的蛋白质绘画化学来分离和测序癌症相关蛋白质的蛋白质-蛋白质相互作用结构域。溶液中相互作用的天然蛋白质被描绘成
用颜料分子的调色板覆盖蛋白质的暴露表面,但不能进入内部蛋白质-蛋白质接触域。因此,如果两个天然蛋白质结合在一起,界面结构域将保持非着色。蛋白质涂料涂层具有高分辨率(<3个氨基酸)。在绘画之后,相互作用的蛋白质被解离,以揭示和暴露当蛋白质在其天然状态下相互作用时油漆分子不可接近的非绘画相互作用结构域。即使在解离后,着色区域也被蛋白酶切割或抗体识别掩蔽。然后可以对解离的着色蛋白进行蛋白酶切割(例如胰蛋白酶)和ms测序或抗体探测。由于涂料阻断不接触的蛋白酶切割位点,用于ms测序的蛋白酶片段将仅从仅包含相互作用结构域的非涂料区域产生。本发明的目的在于我们发现了通过磺化蒽有机染料分子“涂料”如1-氨基-9,10-二氧代-4- [3-(2-磺酰氧基乙基磺酰基)苯胺基]蒽-2 -磺酸二钠掩蔽胰蛋白酶切割位点(精氨酸和赖氨酸的羧基侧),其实现了高度的胰蛋白酶切割位点覆盖。我们通过直接对白细胞介素-1结合其受体的隐藏相互作用域进行质谱测序,验证了蛋白质绘画能力。在过去,这个畴只能用X射线晶体学来预测.我们的变革性技术解决了癌症生物学和癌症治疗领域广泛而关键的未满足需求。我们设想,该技术可以在未来用于破译来自肿瘤活检样本或用配体或疗法处理的细胞培养物的相互作用域。抗体结合测定可用于定量细胞裂解物中占据的结合位点的数量/类型。我们将创建一组12种蛋白质涂料,并将涂料应用于3种癌症相关的蛋白质-蛋白质相互作用模型:1)受体-配体,2)磷酸化介导的缔合,以及3)转录因子复合物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lance Allen Liotta其他文献
Lance Allen Liotta的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lance Allen Liotta', 18)}}的其他基金
Targeting Rab6-km23-1-mediated compartmentalized trafficking as a novel therapeutic approach to Alzheimers Disease
靶向 Rab6-km23-1 介导的区室化运输作为阿尔茨海默病的新型治疗方法
- 批准号:
9756263 - 财政年份:2018
- 资助金额:
$ 24.47万 - 项目类别:
Protein painting identifies therapeutic targets at protein-protein interfaces
蛋白质绘画识别蛋白质-蛋白质界面的治疗靶点
- 批准号:
9392299 - 财政年份:2016
- 资助金额:
$ 24.47万 - 项目类别:
Protein painting identifies therapeutic targets at protein-protein interfaces
蛋白质绘画识别蛋白质-蛋白质界面的治疗靶点
- 批准号:
9338200 - 财政年份:2016
- 资助金额:
$ 24.47万 - 项目类别:
Probes to target the 3-way hotspot of IL1RacP to abolish aberrant interleukin inflammation
靶向 IL1RacP 3 路热点以消除异常白细胞介素炎症的探针
- 批准号:
9085212 - 财政年份:2015
- 资助金额:
$ 24.47万 - 项目类别:
Probes to target the 3-way hotspot of IL1RacP to abolish aberrant interleukin inflammation
靶向 IL1RacP 3 路热点以消除异常白细胞介素炎症的探针
- 批准号:
8944833 - 财政年份:2015
- 资助金额:
$ 24.47万 - 项目类别:
Protein Painting reveals hidden protein-protein interaction domains
蛋白质绘画揭示了隐藏的蛋白质-蛋白质相互作用域
- 批准号:
8728792 - 财政年份:2013
- 资助金额:
$ 24.47万 - 项目类别:
Nanotrap technology for one step preservation and amplification of cancer biomark
Nanotrap 技术可一步保存和扩增癌症生物标志物
- 批准号:
8548317 - 财政年份:2012
- 资助金额:
$ 24.47万 - 项目类别:
Nanotrap technology for one step preservation and amplification of cancer biomark
Nanotrap 技术可一步保存和扩增癌症生物标志物
- 批准号:
8433072 - 财政年份:2012
- 资助金额:
$ 24.47万 - 项目类别:
Nanotrap technology for one step preservation and amplification of cancer biomark
Nanotrap 技术可一步保存和扩增癌症生物标志物
- 批准号:
8723137 - 财政年份:2012
- 资助金额:
$ 24.47万 - 项目类别:
Implementation of phosphoprotein preservation technology for cancer biospecimens
癌症生物样本磷蛋白保存技术的实现
- 批准号:
8311650 - 财政年份:2011
- 资助金额:
$ 24.47万 - 项目类别:
相似海外基金
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10506915 - 财政年份:2021
- 资助金额:
$ 24.47万 - 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10325006 - 财政年份:2021
- 资助金额:
$ 24.47万 - 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
- 批准号:
1746198 - 财政年份:2018
- 资助金额:
$ 24.47万 - 项目类别:
Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
- 批准号:
512537-2017 - 财政年份:2017
- 资助金额:
$ 24.47万 - 项目类别:
University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
- 批准号:
1404605 - 财政年份:2014
- 资助金额:
$ 24.47万 - 项目类别:
Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
- 批准号:
1263713 - 财政年份:2013
- 资助金额:
$ 24.47万 - 项目类别:
Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
- 批准号:
425749-2012 - 财政年份:2012
- 资助金额:
$ 24.47万 - 项目类别:
Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
- 批准号:
1159886 - 财政年份:2012
- 资助金额:
$ 24.47万 - 项目类别:
Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
- 批准号:
19560760 - 财政年份:2007
- 资助金额:
$ 24.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
- 批准号:
234753-2000 - 财政年份:2003
- 资助金额:
$ 24.47万 - 项目类别:
Collaborative Research and Development Grants